These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2731407)

  • 1. Calcium antagonists in geriatric patients: diltiazem in elderly persons with hypertension.
    Montamat SC; Abernethy DR
    Clin Pharmacol Ther; 1989 Jun; 45(6):682-91. PubMed ID: 2731407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Responses to intravenous and oral diltiazem in elderly and younger patients with systemic hypertension.
    Schwartz JB; Abernethy DR
    Am J Cardiol; 1987 May; 59(12):1111-7. PubMed ID: 3578052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of amlodipine, a long-acting dihydropyridine calcium antagonist in aging hypertension: pharmacodynamics in relation to disposition.
    Abernethy DR; Gutkowska J; Winterbottom LM
    Clin Pharmacol Ther; 1990 Jul; 48(1):76-86. PubMed ID: 2142447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute and chronic studies of diltiazem in elderly versus young hypertensive patients.
    Abernethy DR; Montamat SC
    Am J Cardiol; 1987 Dec; 60(17):116I-120I. PubMed ID: 3687802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of amlodipine and diltiazem on 24-hour blood pressure, plasma catecholamines, and left ventricular mass.
    Leenen FH; Fourney A
    Am J Cardiol; 1996 Jul; 78(2):203-7. PubMed ID: 8712143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of calcium antagonists in the treatment of essential hypertension.
    Klein W; Brandt D; Vrecko K; Härringer M
    Circ Res; 1983 Feb; 52(2 Pt 2):I174-81. PubMed ID: 6831651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demographic factors and the antihypertensive effect of diltiazem.
    Elkik F; Claudel S; Carcone B; Grippon P
    J Cardiovasc Pharmacol; 1991 May; 17(5):685-91. PubMed ID: 1713981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and pharmacodynamics of intravenous diltiazem in patients with atrial fibrillation or atrial flutter.
    Dias VC; Weir SJ; Ellenbogen KA
    Circulation; 1992 Nov; 86(5):1421-8. PubMed ID: 1423955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihypertensive efficacy and safe use of once-daily sustained-release diltiazem in the elderly: a comparison with captopril. The Dilcacomp Study Group.
    Nicaise J; Neveux E; Blondin P
    J Int Med Res; 1995; 23(4):244-53. PubMed ID: 7589767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypotensive effects of diltiazem to normals and essential hypertensives.
    Aoki K; Sato K; Kondo S; Yamamoto M
    Eur J Clin Pharmacol; 1983; 25(4):475-80. PubMed ID: 6360693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute treatment of arterial hypertension using calcium antagonists: comparison between diltiazem and nifedipine].
    Arigoni C; Rusca A; Pusterla CE; Beretta-Piccoli C
    Schweiz Med Wochenschr; 1987 Jul; 117(30):1152-7. PubMed ID: 3313686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, controlled trial comparing diltiazem, hydrochlorothiazide, and their combination in the therapy of essential hypertension.
    Pool PE; Applegate WB; Woehler T; Sandall P; Cady WJ
    Pharmacotherapy; 1993; 13(5):487-93. PubMed ID: 8247917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of graded-release diltiazem versus ramipril, dosed at bedtime, on early morning blood pressure, heart rate, and the rate-pressure product.
    White WB; Lacourciere Y; Gana T; Pascual MG; Smith DH; Albert KS
    Am Heart J; 2004 Oct; 148(4):628-34. PubMed ID: 15459593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased sensitivity to diltiazem hypotensive effect in an experimental model of high-renin hypertension.
    Bertera FM; Mayer MA; Opezzo JA; Taira CA; Höcht C
    J Pharm Pharmacol; 2009 Jan; 61(1):79-87. PubMed ID: 19126300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of calcium antagonist (diltiazem) on left ventricular diastolic properties in essential hypertension: a pulsed Doppler echocardiographic study].
    Wada S; Morita H; Senda S; Mizushige K; Nakajima S; Lim YJ; Takamitsu Y; Matsuo H
    J Cardiogr; 1985 Sep; 15(3):753-9. PubMed ID: 3837065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Verapamil disposition and cardiovascular effects in elderly patients after single intravenous and oral doses.
    Carosella L; Menichelli P; Alimenti M; Zuccala G; Gemma A; Cocchi A; Carbonin PU
    Cardiovasc Drugs Ther; 1989 Jun; 3(3):417-25. PubMed ID: 2487538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-monodesmethyldiltiazem is the predominant metabolite of diltiazem in the plasma of young and elderly hypertensives.
    Montamat SC; Abernethy DR
    Br J Clin Pharmacol; 1987 Aug; 24(2):185-9. PubMed ID: 3620292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in the acute pulmonary vascular effects of oxygen with nitric oxide and diltiazem: implications for the long-term treatment of pulmonary arterial hypertension.
    Day RW
    Congenit Heart Dis; 2013; 8(1):71-7. PubMed ID: 22891699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The determinants of response to diltiazem in hypertension.
    Shepherd AM; LeForce C; Park GD; Hoop RS; Weir S
    Clin Pharmacol Ther; 1991 Sep; 50(3):338-49. PubMed ID: 1914368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of diltiazem on lipid profiles and heart rate in hypertensive patients].
    Carré A; Joire JE; Mounier-Vehier C; Lequeuche B
    Ann Cardiol Angeiol (Paris); 1999 Mar; 48(3):221-6. PubMed ID: 12555384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.